Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Evelo Biosciences Inc

(NASDAQ: EVLO)
Ajouter à Portefeuille
+0,09 (+1,60%)
en date du 15:12 EST

Profil
Symbole EVLO
Marché NASDAQ
Informations de contact
620 Memorial Drive Suite 500 West
Cambridge, MA USA
P: 617-577-0300
Président Balkrishan (Simba) Gill
Bénéfices à vue d'oeuil
Bénéfices 09/30/19
-0.67
06/30/19
-0.65
03/31/19
-0.64
12/31/18
1.86
Ratio prix/bénéfices N/A
Croissance du BPA 8,27
Most Recent Earnings ($) -0,67
Annual EPS ($) -2,45
Résumé business
Evelo Biosciences Inc. operates as a bio-technology company. It develops therapies for the treatment of the gut-body network. The company also offers treatment for cancer and inflammatory diseases. Its product portfolio consists of EDP1066 which are in clinical stage. Evelo Biosciences is based in Massachusetts United States.
Industrie/Secteur SIC-2834 Pharmaceutical Preparations
Medical - Biomedical
Indices Nasdaq Composite
Indices Russell 3000
Indices Russell 2000